Jaguar Health, Inc. Uncategorized Contracts & Agreements

55 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third ATM Amendment, dated July 17, 2024, to ATM Agreement by and among Jaguar Health, Inc., Ladenburg Thalmann & Co. Inc. and Lucid Capital Markets, LLC
Jaguar Health, Inc.
Pharmaceuticals
2024
Second Amendment to the At the Market Offering Agreement, dated May 23, 2024, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
2024
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment, dated September 29, 2023, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Uptown Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2, dated September 29, 2023, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
2023
First Amendment to the Standstill Agreement, dated June 28, 2023, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., Iliad Research and Trading, L.P., Uptown Capital,...
Jaguar Health, Inc.
Pharmaceuticals
2023
Second Amendment to the Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
2023
Standstill Agreement
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Global Amendment, dated October 17, 2022, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Royalty Interest, dated August 24, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
First Amendment to the Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Uptown Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment, dated April 14, 2022, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
2022
First Amendment to the At the Market Offering Agreement, dated February 2, 2022, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
2022
At The Market Offering Agreement, dated December 10, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2021
Royalty Interest, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Royalty Interest, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Royalty Interest, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
At The Market Offering Agreement, dated October 5, 2020, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2020
Global Amendment, dated September 1, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
2020
Jaguar Health, Inc. New Employee Inducement Award Plan
Jaguar Health, Inc.
Pharmaceuticals
CA
2020
Form of Inducement Letter for Bridge Warrants
Jaguar Health, Inc.
Pharmaceuticals
2020
Form of Inducement Letter for Original Warrants
Jaguar Health, Inc.
Pharmaceuticals
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1945, as amended
Jaguar Health, Inc.
Pharmaceuticals
2020
Leak-Out Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein
Jaguar Health, Inc.
Pharmaceuticals
2020
Royalty Interest, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2020
Lock-Up Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC
Jaguar Health, Inc.
Pharmaceuticals
NY
2019
Promotion Letter, dated September 6, 2019
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Leak-out Agreement
Jaguar Health, Inc.
Pharmaceuticals
2019
Form of Amendment Agreement
Jaguar Health, Inc.
Pharmaceuticals
2019
Standstill Agreement, dated October 1, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Co-Promotion Agreement, dated June 28, 2018, by and between Napo Pharmaceuticals, Inc. and RedHill Biopharma, Inc
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Offer Letter, dated May 25, 2018
Jaguar Health, Inc.
Pharmaceuticals
2018
Offer Letter, dated May 25, 2018
Jaguar Health, Inc.
Pharmaceuticals
2018
Consent and Payoff Agreement, dated February 27, 2018, by and between Napo Pharmaceuticals, Inc. and the purchasers named therein
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Letter Agreement, dated October 25, 2017, by and between Jaguar Health, Inc. and Maxim Group LLC
Jaguar Health, Inc.
Pharmaceuticals
2017
Letter Agreement, dated August 30, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Jaguar Health, Inc.
Pharmaceuticals
2017